Press Resease

Proteomics Market by Component (Reagents and Instruments) and by Application (Disease Diagnosis, Drug Discovery, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 22-Mar-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-2326 Status : Published

Global proteomics market expected to generate around USD 43.7 billion by 2025, at a CAGR of around 14.9% between 2019 and 2025. Proteomics encompasses the extensive learning of proteins, their assembly, and physiological part or roles. Proteins are essential cellular constituents or biomolecules in living organisms.

Description

The report covers a forecast and an analysis of the proteomics market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the proteomics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the proteomics market on a global and regional level.

In order to give the users of this report a comprehensive view of the proteomics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Proteomics Market

The report provides company market share analysis to give a broader overview of the key players in the proteomics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the proteomics market on a global and regional basis.

The study provides a decisive view of the proteomics market by segmenting the market based on component, application, and region. Based on the component, the proteomics market is bifurcated into reagents and instruments. Reagents are sub-segmented into spectroscopy, microarray, X-ray crystallography, electrophoresis, chromatography, protein fractionation reagents, immunoassay, and services. Instruments are sub-segmented into spectrometry, protein microarray, chromatography, surface plasmon resonance, electrophoresis, protein fractionation systems, and X-ray crystallography. The application segment is divided into disease diagnosis, drug discovery, and others.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with it's further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global proteomics market are Agilent Technologies, Thermo Fisher Scientific Corporation, Luminex Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Inc., GE Healthcare, Caprion Proteomics Inc., PerkinElmer, Inc., and Waters Corporation, among others.

This report segments the global proteomics market into:

Global Proteomics Market: By Component

  • Reagents
    • Spectroscopy
    • Microarray
    • X-Ray Crystallography
    • Electrophoresis
    • Chromatography
    • Protein Fractionation Reagents
    • Immunoassay
    • Services
  • Instruments
    • Spectrometry
    • Protein Microarray
    • Chromatography
    • Surface Plasmon Resonance
    • Electrophoresis
    • Protein Fractionation Systems
    • X-ray Crystallography

Global Proteomics Market: By Application

  • Disease Diagnosis
  • Drug Discovery
  • Others

Global Proteomics Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Proteomics market, 2016-2025 (USD Billion)
    • 2.2. Global Proteomics market: Snapshot
  •  
  • Chapter 3. Proteomics Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Growing demand for personalized medicines
      • 3.2.2. Increasing expenditure on research and development
    • 3.3. Market Restraints
      • 3.3.1. High instrument costs
      • 3.3.2. The lack of skilled research professionals
    • 3.4. Opportunities
      • 3.4.1. Efforts taken by governments to fast track research and development activities
      • 3.4.2. Growing investments by leading companies
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Component
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Proteomics Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Proteomics market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Proteomics Market - Component Analysis
    • 5.1. Global Proteomics market: Component overview
      • 5.1.1. Global Proteomics market revenue share, by Component, 2018 and 2025
    • 5.2. Reagents
      • 5.2.1. Global Proteomics market for Reagents, 2016-2025 (USD Billion)
    • 5.3. Instruments
      • 5.3.1. Global Proteomics market for Instruments, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Proteomics Market - Application Segment Analysis
    • 6.1. Global Proteomics market: Application overview
      • 6.1.1. Global Proteomics market revenue share, by Application, 2018 and 2025
    • 6.2. Disease Diagnosis
      • 6.2.1. Global Proteomics market for Disease Diagnosis, 2016-2025 (USD Billion)
    • 6.3. Drug Discovery
      • 6.3.1. Global Proteomics market for Drug Discovery, 2016-2025 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global Proteomics market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Proteomics Market - Regional Analysis
    • 7.1. Global Proteomics market: Regional overview
      • 7.1.1. Global Proteomics market revenue share, by region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Proteomics market revenue, by Component, 2016-2025 (USD Billion)
      • 7.2.2. North America Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.2.3.2. The U.S. Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.2.4. Rest of North America
        • 7.2.4.1. Rest of North America Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.2.4.2. Rest of North America Proteomics market revenue, by Application, 2016-2025 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Proteomics market revenue, by Component, 2016-2025 (USD Billion)
      • 7.3.2. Europe Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.3.3.2. Germany Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.3.4. UK
        • 7.3.4.1. UK Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.3.4.2. UK Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.3.5.2. France Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.3.6. Rest of Europe
        • 7.3.6.1. Rest of Europe Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.3.6.2. Rest of Europe Proteomics market revenue, by Application, 2016-2025 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Proteomics market revenue, by Component, 2016-2025 (USD Billion)
      • 7.4.2. Asia Pacific Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.4.3.2. China Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.4.4.2. Japan Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.4.5.2. India Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.4.6. Rest of Asia Pacific
        • 7.4.6.1. Rest of Asia Pacific Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.4.6.2. Rest of Asia Pacific Proteomics market revenue, by Application, 2016-2025 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Proteomics market revenue, by Component, 2016-2025 (USD Billion)
      • 7.5.2. Latin America Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.5.3.2. Brazil Proteomics market revenue, by Application, 2016-2025 (USD Billion)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America Proteomics market revenue, by Component, 2016-2025 (USD Billion)
        • 7.5.4.2. Rest of Latin America Proteomics market revenue, by Application, 2016-2025 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Proteomics market revenue, by Component, 2016-2025 (USD Billion)
      • 7.6.2. The Middle East and Africa Proteomics market revenue, by Application, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Company Profile
    • 8.1. Agilent Technologies
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Drug Component portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. Thermo Fisher Scientific Corporation
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Drug Component portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Luminex Corporation
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Drug Component portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Bio-Rad Laboratories, Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Drug Component portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Danaher Corporation, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Drug Component portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. GE Healthcare
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Drug Component portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Caprion Proteomics Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Drug Component portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. PerkinElmer, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Drug Component portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Waters Corporation
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Drug Component portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments

Methodology

Free Analysis

Proteomics is the comprehensive study of proteomes, which are basically a lot of proteins that are manufactured or altered by an organism or structure. Proteomics enables the identification of a vast number of proteins. The proteomes vary from cell to cell and deviate over time. Proteomics reveals substantial biological information that plays an important role in disease diagnosis and drug discovery. Developments in mass spectrometry, protein fractionation practices, and bioinformatics have increased the significance of proteomics. The use of proteomics has transformed drug discovery entirely. The analysis of transcription, side effect outlining, pharmacogenomics, and biomarker identification are vital in the process of drug discovery.

The growing demand for personalized medicines, increasing expenditure on research and development by the leading market players, various technological advancements, rising awareness regarding multiple applications of proteomics, increasing case of genetic disorders, the ability of proteomics to bridge the gap between cellular behavior and genome expression, and rapid implementation of latest technologies in developed regions are majorly driving the growth of the global proteomics market. Governmental efforts to fast track research and development activities will create new opportunities for the market players in the global proteomics market in the years ahead. However, the high cost of instruments, the dearth of skilled research professionals, and lack of awareness regarding proteomics and its applications in developing regions may restrict the global proteomics market.

Global Proteomics Market

The global proteomics market is split into component and application. Based on the component, the proteomics market is segmented into reagents and instruments. The reagents segment held the largest market share in 2018, due to the rising product use for separation of protein from intricate mixtures and additional proteome investigation measures. Reagents are sub-segmented into spectroscopy, microarray, X-ray crystallography, electrophoresis, chromatography, protein fractionation reagents, immunoassay, and services. Instruments are sub-segmented into spectrometry, protein microarray, chromatography, surface plasmon resonance, electrophoresis, protein fractionation systems, and X-ray crystallography. The application segment is divided into disease diagnosis, drug discovery, and others. Drug discovery held the largest market share in 2018, due to multiple advantages offered by proteomics technology in the drug discovery process.

By region, North America will be the leading region over the forecast time period in the global proteomics market. The growing implementation of tailored medicine, positive government initiatives, huge investments in research and development, increasing investments made by academic institutions in proteomics and genomics research, and the presence of the state-of-the-art healthcare facilities are driving the region’s proteomics market. Europe will be the second largest proteomics market globally in the future, owing to the presence of skilled researchers, high R&D investment made by leading companies, increasing geriatric population, the rising prevalence of chronic disorders, and positive reimbursement scenario. The Asia Pacific proteomics market will grow at a speedy rate over the forecast time period due to the rising incidence of chronic diseases, growing interest in proteomics, increasing research and development on proteomics applications, and growing use of proteomics in disease diagnosis and therapy.

Some key players of the global proteomics market are Agilent Technologies, Thermo Fisher Scientific Corporation, Luminex Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Inc., GE Healthcare, Caprion Proteomics Inc., PerkinElmer, Inc., and Waters Corporation, among others.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com